Russian Intranasal Vaccine Effective Against All Coronavirus Strains - Developers

MOSCOW (Sputnik) - The new Russian nasal vaccine against COVID-19 has demonstrated effectiveness against all variants of the coronavirus, Alexander Gintsburg, the director of Russia's Gamaleya Research Center for Epidemiology and Microbiology, which developed the vaccine, told Sputnik. "We’ve observed that the currently available and already registered intranasal vaccine is demonstrating high efficiency in protecting against all strains [of the coronavirus], forming mucosal immunity to the pathogen," Gintsburg said. The Russian Health Ministry registered the world’s first intranasal vaccine against COVID-19 in April. Gintsburg told Sputnik in March that the new vaccine was effective against the Omicron variant. He said that the new vaccine was going to be used as a booster, in addition to the Sputnik V shots, until there was enough evidence that this new intranasal method gives the same level of protection as an injection. In November of last year, Russian President Vladimir Putin offered to become a volunteer in the testing of the new vaccine and said that he felt no side effects after getting the procedure. Russia became the first country in the world to register a vaccine against COVID-19, dubbed Sputnik V, in August 2020. The Russian Health Ministry has also registered a new, Sputnik M, vaccine for adolescents aged 12-17. Clinical trials of Sputnik shots for children aged 6-11 are currently underway in Moscow, according to Gintsburg. Read more: https://sputniknews.com/20220815/russian-intranasal-vaccine-effective-against-all-coronavirus-strains---developers-1099595203.html